Giulia Mosini

3PUBLICATIONS
13CO-AUTHORS
Toxicology (incl. clinical toxicology)Epidemiological modellingEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 06, 2025
Olmesartan-Induced Enteropathy: Case Reports and Insights From FDA Adverse Event Reporting System (FAERS).

Ilaria Mariani, Giulia Mosini, Stefania Cheli

|May 07, 2025
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort.

Marco Schiuma, Sofia Dinegro, Vera Battini

|Dec 27, 2024
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.

Stefania Cheli, Alessandro Torre, Marco Schiuma

Pageof 1